Natrunix Program
Rheumatoid Arthritis
Not SpecifiedActive
Key Facts
About XBiotech
XBiotech is dedicated to discovering and developing therapeutic antibodies sourced directly from human donors with natural immunity, a platform it calls True Human™. The company has achieved a significant milestone with the $750M sale of an IL-1α antibody and is advancing a pipeline in oncology, neurology, rheumatology, and anti-infectives. With a state-of-the-art manufacturing facility in Austin, Texas, XBiotech aims to create breakthrough therapies with improved safety profiles by leveraging the body's own immune defenses.
View full company profileTherapeutic Areas
Other Rheumatoid Arthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| Early Detection Test for Rheumatoid Arthritis | Age Labs | Development |
| CORTONE (cortisone) | Merck | Commercial |
| Kevzara (sarilumab) | Regeneron Pharmaceuticals | Approved |
| Actemra (tocilizumab) | Chugai Pharmaceutical | Approved |
| Tocilizumab | Biocon | Filed |
| Humira | Abbott India | Approved |
| KPL-404 | Kiniksa Pharmaceuticals | Phase 2 |
| Tibulizumab (ZB-106) | Zura Bio | Phase 1b |
| Zunsemetinib (ATI-450) | Aclaris Therapeutics | Phase 2b |
| LEAPS Technology | CEL-SCI | Pre-clinical |
| Piclidenoson (CF101) | Can Fite Biopharma | Phase 3 |
| Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure) | LFB | Pre-clinical |